Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 10, 2023, titled "Zydus receives EIR for the Pre-Approval Inspection (PAI) at the manufacturing facility in Moraiya, Ahmedabad".
Press Release May 10 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its manufacturing facility in Moraiya, Ahmedabad. The inspection, which focused on transdermal patch products, concluded with no observations. This disclosure is made in accordance with regulatory requirements to inform investors and exchange members.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release May 04 2023
- Press Release Apr 25 2023
- Press Release Apr 24 2023
- Press Release Apr 20 2023
- Press Release Apr 19 2023
Later from Zydus Lifesciences
- Press Release May 17 2023
- Press Release May 18 2023
- Press Release Jun 07 2023
- Press Release Jun 08 2023
- Press Release Jun 09 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences